Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition
Cited by 36
Related Papers
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
|Nature Communications|2021|143
Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways
|Acta Pharmacologica Sinica|2020|41
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
|Cancer Cell International|2019|33
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
|Cell Death and Disease|2021|19
IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma
|International Journal of Biological Sciences|2022|9